Trials / Terminated
TerminatedNCT00320918
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
Chart Review on Patients With Unresectable/Metastatic Cholangiocarcinoma Treated in the UNM Cancer Center With a Combination of Irinotecan, Capecitabine and Celecoxib
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- University of New Mexico · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Chart Review on Patients with unresectable/metastatic cholangiocarcinoma treated in the UNM Cancer Center with a combination of irinotecan, capecitabine and celecoxib.
Detailed description
As above.
Conditions
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2006-08-01
- Completion
- 2006-10-01
- First posted
- 2006-05-03
- Last updated
- 2024-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00320918. Inclusion in this directory is not an endorsement.